glp-1 gip dual agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica TrimRX | GLP-1 vs GIP:
Description
Indication 18.8.7
Copycat products and inadequate oversight: We already have a troubling market of compounded products, "research" peptides, microdosing plans, longevity packages, and cosmetic weight-loss programs with inadequate medical supervision
the results also demonstrated that these doses led to significant reductions in body weight
The crystal structures of un-acylated liraglutide and semaglutide are almost identical to GLP-1 (97)
The main difference lies in how they work in the body: Semaglutide : Targets the GLP-1 receptor only, enhancing the bodys natural fullness signals and slowing digestion
The mechanism(s) has not been delineated, and further investigation is needed
